Avono Health Tirzepatide Review: Formats, Price & Billing
Researched & written by Alan PierceClinical Pharmacology WriterUpdated
On this page
Standard tirzepatide injection has its own monthly price; microdose and oral options are separate offers.
Standout details
- Public selected pricing separates four tirzepatide preparation and program options
- Named standard injection lists no membership fee, no clinician fee and free shipping
Things to consider
- Different dose and oral formats do not establish clinical equivalence
- Medication-order nonapproval exception does not resolve every possible separate service fee
Avono Health’s named Tirzepatide Injection page advertises $299 per month, without a separate membership or clinician fee and with free shipping. Its pricing menu lists different amounts for microdose injection, microdose oral-dissolving and oral options. These are separate formulations and programs; the cheapest card is not a universal tirzepatide quote.3,4
Match the price to the prescribed preparation
The menu lists $219 per month for Microdose Tirzepatide Injection, $239 for Microdose Tirzepatide ODT and $349 for Tirzepatide Oral, alongside the $299 injection. A shared ingredient name does not establish route, dose, absorption, supplied quantity or clinical equivalence. Do not choose a regimen from a price table.4
Obtain the actual selected total, number of supplied weeks, first collection date and later renewal. The product’s no-clinician-fee description does not establish that every possible additional test or service is included; the Terms allow charges disclosed for the selected services, including laboratory and other costs.3,6
Avono: compare separate preparations
| Published detail | Decision before payment |
|---|---|
| Tirzepatide Injection: $299/month | Confirm prescribed supply and full charge. |
| Microdose Injection: $219/month | A separate lower-dose program label. |
| Microdose ODT: $239/month | An oral-dissolving option, not injection evidence. |
| Tirzepatide Oral: $349/month | Discuss route-specific evidence with the clinician. |
Authorization is different from a completed charge
The FAQ says a payment authorization occurs during intake and may appear as Care Validate, but is not a completed charge. If treatment is approved and prescribed, the authorized payment completes; if treatment is not approved, the medication order is not charged. Obtain the actual authorization amount and release process without assuming a bank-processing time.5
The broader Terms allow fees at different stages, including before clinical approval, and generally make fees nonrefundable once a provider reviews intake or other listed services begin. Ask whether any evaluation or nonmedication fee remains if treatment is declined, and which agreement governs the selected order. The FAQ’s medication-charge exception should be preserved rather than silently replaced by general final-sale wording.5,6
Cancel before the selected processing cutoff
For recurring plans, the Terms authorize charges at the disclosed interval until cancellation. They require cancellation before the selected renewal or processing cutoff, without establishing one universal public notice period for every product. Ending renewal does not necessarily stop an order already submitted for clinical review, compounding, dispensing or shipment.6
The Terms generally exclude refunds after services, intake review, prescription issuance, pharmacy processing, laboratory ordering or fulfillment, subject to applicable rights or an express written exception. Ask for the actual stage, amount still owed and effective cancellation date. A medication already dispensed or shipped is generally not returnable.6
For an incorrect charge or shipment issue, contact support promptly and preserve documentation. Obtain the applicable written exception and pharmacy instructions before attempting to return a prescription.6
Avono: payment and order stages
| Published detail | Decision before payment |
|---|---|
| FAQ: intake authorization | Not a completed medication charge. |
| Approved and prescribed | FAQ says the authorization completes. |
| Treatment not approved | FAQ says no medication-order charge. |
| Clinical review or pharmacy processing | Clarify separate fees and cancellation limits. |
Public medical and pharmacy networks are identified
The Medical Oversight page describes CareValidate supporting intake, review, communications and pharmacy coordination, with medical services potentially provided by Lion MD and other independent clinical partners. It names clinicians but does not establish the actual provider assigned to an individual request or independently verify current credentials.7
It also names Belmar Pharmacy, Strive Pharmacy, Epi Scripts and Casa Pharma Rx in its pharmacy-provider network. This supports a public Network description; individual assignment is a separate question. Do not infer 503A/503B status or FDA approval from those names. Confirm the actual treating practice, dispenser, location eligibility, prescription and label instructions.7
Clinical evidence and individual care
Compounded tirzepatide is not an FDA-approved finished drug.8 SURMOUNT-1 and SURMOUNT-5 studied specific products and treatment protocols; they do not establish this service’s outcomes or equivalence of a compounded preparation, microdose regimen or oral formulation.1,2 Confirm the actual prescription, risks, alternatives and label instructions with the treating clinician.
Further reading
whether compounded tirzepatide is still legal in 2026 · Zepbound side effects · the gallbladder risk · thyroid cancer warning · tirzepatide evidence guide · ShedRx · best tirzepatide providers
Frequently asked questions
Is every Avono tirzepatide option $299 per month?
No. That is the named Tirzepatide Injection amount. The menu separately lists microdose injection, microdose ODT and oral options with different prices. Obtain the clinician-selected formulation and full supply quote.
What does a Care Validate authorization mean?
The FAQ says the intake authorization is not a completed charge. It completes for an approved, prescribed treatment; an unapproved medication order is not charged. Confirm any separate service fees and bank release timing.
Does Avono publish pharmacy partners?
Yes. The Medical Oversight page names Belmar, Strive, Epi Scripts and Casa Pharma Rx as network members. Ask which actual pharmacy will prepare and dispense the prescription; the list does not independently verify current licenses.
References(8)
- Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
- Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
- Avono Health (2026). Tirzepatide Injection: named monthly price and treatment description. Avono Health.
- Avono Health (2026). Pricing: distinct injection, oral and microdose offers. Avono Health.
- Avono Health (2026). FAQ: authorization, approval, shipping and support. Avono Health.
- Avono Health (2026). Terms of Use: recurring payments, clinical-review finality and independent roles. Avono Health.
- Avono Health (2026). Medical Oversight: CareValidate, clinical partners and named pharmacy network. Avono Health.
- U.S. Food and Drug Administration (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration. Read source
About the author
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Browse provider reviewsShed Tirzepatide Review: Plan Prices, Supply & Guarantee
Shed lists $299 monthly tirzepatide injections and longer-plan discounts. Review supply periods, cancellation repricing and the conditional 120-day guarantee.
ReadIs Compounded Tirzepatide Still Legal in 2026?
Tirzepatide's shortage ended in 2024 and FDA's compounding grace period closed in early 2025. Here's the precise legal status of compounded tirzepatide in 2026.
ReadZepbound Side Effects: Full Breakdown by Frequency
Compare common Zepbound side effects by dose, see trial frequencies and learn which warning signs need prompt medical attention.
ReadTirzepatide and Gallbladder Problems
How often tirzepatide causes gallstones and cholecystitis, why rapid weight loss is part of it, and the red-flag symptoms that need urgent care.
ReadTirzepatide Thyroid Cancer Warning Explained
What tirzepatide's boxed thyroid C-cell tumor warning actually means: verbatim FDA label text, the rat data behind it, and what human evidence shows.
ReadTirzepatide: Evidence, Dosing & Side Effects
An evidence-based guide to tirzepatide: how the dual GIP/GLP-1 drug works, what the trials show, the dosing ladder, side effects, and the ongoing-use reality.
Read